CARDIOVASCULAR RESEARCH FOUNDATION (CRF) SOCIAL/PRINT/WEB Heart disease poses a major threat to women’s lives. In fact, only 40% of women report receiving heart health assessments in their annual wellness exams. Left unchecked, heart disease risk f
Copy: High cholesterol brews silently. Left unchecked, it can develop into serious, even deadly heart disease. The killer of 1 in 4 women in the US each year. TAKE ACTION. Talk to your doctor. And learn about heart disease risk factors in women a
Copy: High blood pressure is a silent threat. Left unchecked, it can develop into serious, even deadly heart disease. The killer of more women than all cancers combined. TAKE ACTION. Talk to your doctor. And learn about heart disease risk factor
LittleMonsters_Phase02_R2.jpg
SEEBRI from NOVARTIS for COPD An inhaler for the treatment of patients with COPD. Chronic Obstructive Pulmonary Disorder is a progressive disease often caused by smoking, that destroys the structure of the lungs. Suffocation is the word most used
Seebri_glenn_sq_space2.jpg
Seebri_glenn_sq_space3.jpg
SURVIVORS COLLECTION from GENENTECH+TIFFANY. In a fusion of science and artistry, the SURVIVORS COLLECTION (concept prototype) envisions a unique collaboration between Genentech and Tiffany & Co., creating a platform that honors female cancer s
Suvivors collection jewelry2.jpg
Suvivors collection jewelry3.jpg
Suvivors collection jewelry4.jpg
Suvivors collection jewelry5.jpg
Suvivors collection jewelry6.jpg
Suvivors collection jewelry7.jpg
Suvivors collection jewelry8.jpg
Suvivors collection jewelry9.jpg
Suvivors collection jewelry10.jpg
GIVE.ORG. PRINT. SOCIAL Charitable donors want to give their money to good causes, but don’t necessarily know how individual charities ultimately spend their money. Our goal was to let donors know that give.org offers a detailed look into the finan
MicrosoftTeams-image.png
SickMoney_ENTRAPPED_RGB_01BB.jpg
GIVE.ORG. ACTIVATION Our goal: let donors know that give.org offers a detailed look into the financial health of charities. We placed a coffin filled with “our bills” in one of the busiest locations in NYC. In addition, a poster of the deceased cas
GENENTECH. CANCER SCREENING AWARENESS What if we can save lives through the expression of love? We asked members of the African American/Hispanic communities to write love letters to the women in their lives to express, in their own words, how much
Lilli.jpg
Amanda.jpg
GENENTECH. CANCER SCREENING AWARENESS ACTIVATION WIP billboard for the LOVE LETTERS campaign. QR codes were placed on all content linking women to cancer education and information on local screening centers.
MAGROLIMAB by GILEAD for MDS (MYELODYSPLASTIC SYNDROMES) Magrolimab is a potential, first-in-class investigational monoclonal antibody that binds to CD47. The primary mechanism of action of magrolimab is to block the inhibitory CD47-signal regulato
MAGROLIMAB by GILEAD for MDS. BOOTH
ALBINTERFERON from NOVARTIS for HEPC Medication for the treatment of HepC/liver disease. Patients become depressed and isolated with little hope for recovery. The icon for the brand became a nameless, faceless representation of what it feels like t
HEPC_SHOP_gray.jpg
HEPC_vaccum_gray.jpg
MULTI-LINK VISION STENT from ABBOTT. Device for the treatment of coronary artery disease. A world class patented stent design came to life in a campaign called Tiny Wonders. We took a cue from nature which inspired us in the form of an ant, spi
Abbott_ant_2021.jpg
TAKEDA CORPORATE for NSCLC Lung cancer metastasizes to the brain more than melanoma, renal, breast, and colorectal cancers. Treatment options are fraught with challenges, including a range of CNS side effects, low blood-brain-barrier penetration, a
Takeda_Concepts_Glenn_type updated 20222.jpg
Takeda_Concepts_Glenn_type updated 20223.jpg
AMERICAN ASSOCIATION FOR CANCER RESEARCH. OUTDOOR Copy: Innovative breakthroughs in cancer research show cells are no longer safe. The next generation of treatment is relentless in it’s pursuit of tumors, whose very existence is at stake.
Copy: Innovative breakthroughs in cancer research are now working to capture and eliminate cancer cells at an accelerated rate. It’s happening daily, making extinction a real possibility.
EMD SERONO for RMS. DISEASE AWARENESS LAUNCH While your RMS patients may seem stable…beneath the surface, their abilities are unraveling. In RMS, seeing isn’t always believing. Sub-clinical disease activity can cause disability progression in the a
UNRAVEL CAMPAIGN. EXECUTION DETAILS
HSNY-P00100018-EVBR23-DL12-2023-DSA-Global-Ads-Lobs_GB_dogwoman.jpg
HSNY-P00100018-EVBR23-DL12-2023-DSA-Global-Ads-Lobs_GB3.jpg
LENACAP from GILEAD for HIV It's no longer enough to make HIV undetectable in the patient’s body; we must make the treatment undetectable in the patient’s life. So what was once treating the disease with added burden is now treatment with neither
Lena_boom_pow_green.jpg
TIRAGOLUMAB+TECENTRIQ from GENENTECH for CANCER TIRA will be the first novel agent to target the PD-1/PDL1 pathway, allowing this combination with TECENTRIQ to open the door to extended survival and greater ability to marshal the body’s defenses to
Get cancer2.jpg
TIRAGOLUMAB+TECENTRIQ from GENENTECH for CANCER A short run campaign for a micro sight. A link was sent to HCPs who opted in/attended a Genentech convention conference. Clients desired an atypical concept that raised awareness of the new Tira treat
Tira Trash Talk for laptop3.jpg
Tira Trash Talk for laptop2.jpg
GENENTECH CORPORATE ADVERTISING The Genentech Visionary Campaign is a series designed to communicate Genentech’s continued pursuit of bold scientific discoveries, and how our shared vision connects us in the quest to bring new solutions to HCPs and
jadpro sq space 2 ads.jpg
GILEAD for CANCER. U.S. DISEASE AWARENESS Therapies for hematologic cancers are neglecting the innate immune system—keeping macrophages from their natural food source and keeping HCPs hungry for more effective treatments.
GILEAD for CANCER. GLOBAL DISEASE AWARENESS Therapies for hematologic cancers are neglecting the innate immune system. By keeping macrophages well fed on cancer cells, HCPs are better prepared to effectively fight disease like MDS.
UNBRANDED for BRAF MUTANT METASTATIC MELANOMA from NOVARTIS When it comes to sequencing, should you start with targeted therapies or Immunotherapy? You might as well ask, what came first, the chicken or the egg? The answer is soon to be unveiled
Trumenba_boy_ss.jpg
Trumenba_subway_pizza_ss.jpg
Trumenba_billboard_night_ss.jpg
Trumenba_tactics_ss.jpg
DENGVAXIA from SANOFI for DENGUE FEVER. There is a misconception that Dengue is only a threat to the poor communities of third world countries. But, the virus spreading mosquitoes are adapting to all different kinds of regions and climates at an al
DENGVAXIA from SANOFI for DENGUE FEVER. OUTDOOR
DENGVAXIA from SANOFI for DENGUE FEVER. TRAIN STATION BILLBOARD.
GUARDANT LIQUID BIOPSIES for CANCER Blood is simple, easy, non-invasive and 9 out of 10 times concurrent with tissue biopsies. Guardant is dedicated to helping patients at all stages of cancer live longer and healthier, through the power of blood t
GUARDANT sutures ss2.jpg
Gaurdant-twitter-posts_v4_Page_4.jpg
STEMLINE THERAPEUTICS for BPCDN. MARKET SHAPING for ELZONRIS PROBLEM: BPDCN is a very rare disease. And because it is so rare it falls off the radar of HCPs when diagnosing patients. How do we keep a disease top of mind, when HCPs are unlikely to
ONLINE CONVENTION BOOTH: An immersive digital experience of the Rare Bird BPDCN campaign.
MOA/MOD: A digital bird travels inside the body. AR binoculars, reveals a first person POV. Through the journey BPDCN is ultimately spotted and information is captured through the birds camera eye and emailed to the HCP.
WINGMEN - PEER TO PEER: STEMLINE connects Rare Birds to partner and advise with diagnosis on the “BIRD CALLS” app. BPDCN TRACKER - “RARE BIRD ALERTS”: BPDCN cases are spotted like a flight tracker. HCPs get a live birds eye view as cases are ident
BIRDS OF A FEATHER - YOUTUBE CHANNEL/PODCAST: STEMLINE connects Rare Birds to partner for robust discussion on BPDCN. A digital HALL OF BIRDS highlights those that have been inducted into this rare group. Wing pins are sent to recipients.
PATIENT ADVOCACY GROUP - “BIRD SANCTUARY”: Patient portal connects rare patients. It is monitored by a Rare Bird specialist (HCP) and STEMLINE to advise and answer questions. DOCUMENTARY: On Rare Bird patients, their individual stories and how Rare
prev / next